News Focus
News Focus
icon url

DewDiligence

05/01/18 10:59 AM

#16597 RE: biotech_researcher #16596

PFE lost a lot of revenue (compared to 1Q17) to patent expirations, e.g. Lyrica. This was known beforehand, so it shouldn't be a "show stopper" for anybody.